Business & Finance
Chilean authorities approve J&J's COVID-19 vaccine for emergency use
11 June 2021 -

The Institute of Public Health in Chile has approved the emergency use of a COVID-19 vaccine developed by Belgian laboratory Janssen, a unit of US pharmaceutical Johnson & Johnson (J&J) (NYSE:JNJ), Reuters news agency reported on Friday.

The institute stated: "This vaccine, which requires a single dose, is already authorised in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over."

These single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).

Chile has already authorised the COVID-19 vaccines of BioNTech (Nasdaq:BNTX), Sinovac, AstraZeneca (LON:AZN)/Oxford and CanSino for emergency use.